Clinical trial
Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
NCT01863134 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Lead sponsor
- Medical University of Silesia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- December 31, 2010
- Enrollment
- 140 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
non st elevation myocardial infarction